SmartZyme Team

Scientific Advisory Board

Dr. Ohad Mazor

Ohad Holds Phd in Biochemistry from the Weizmann Institute of science. During the PhD studies he developed “TOOKAD soluble”, a drug that was recently approved in central Ameraca for the treatment of prostate cancer.

Since 2004 Ohad holds a position as a senior scientist at the Israel Institute for Biological Research, leading a group of antibody engineering.
Published more than 20 scientific papers and book chapters and owns 3 patents.

Interested in working with us?